GoodRx Holdings, Inc. Class A Common Stock (GDRX)
NASDAQ · Healthcare
GoodRx Holdings, Inc. Class A Common Stock Gross Profit 2020–2025
GoodRx Holdings, Inc. Class A Common Stock annual/quarterly gross profit history and growth rate from 2020 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- GoodRx Holdings, Inc. Class A Common Stock gross profit for the quarter ending March 31, 2026 was 173.8 M.
- GoodRx Holdings, Inc. Class A Common Stock gross profit for the twelve months ending March 31, 2026 was 723.5 M.
- GoodRx Holdings, Inc. Class A Common Stock annual gross profit for 2025 was 739.3 M, a 0.65% decrease from 2024.
- GoodRx Holdings, Inc. Class A Common Stock annual gross profit for 2024 was 744.1 M, a 8.89% increase from 2023.
- GoodRx Holdings, Inc. Class A Common Stock annual gross profit for 2023 was 683.3 M, a 2.59% decrease from 2022.
- GoodRx Holdings, Inc. Class A Common Stock annual gross profit for 2022 was 701.5 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
GoodRx Holdings, Inc. Class A Common Stock Gross Profit — FAQ
GoodRx Holdings, Inc. Class A Common Stock (GDRX) gross profit over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is GoodRx Holdings, Inc. Class A Common Stock's gross profit?
GoodRx Holdings, Inc. Class A Common Stock (GDRX) reported gross profit of $739M for fiscal 2025.
Where can I see GDRX's gross profit history?
The chart and table above show GoodRx Holdings, Inc. Class A Common Stock's gross profit by year and by quarter, including the growth rate.